Table 3 Univariate analysis of postoperative DVT risk in patients with femoral and pelvic fractures

CRP^a (μg/L)

26.70 (13.11, 62.60)

28.10 (12.57, 66.21)

− 0.428

0.668

Crea^a (μmol/L)

69.00 (55.81, 81.10)

60.01 (44.01, 76.49)

− 5.245

0.000

Urea^a (mmol/L)

6.10 (4.90, 8.00)

6.70 (4.90, 13.20)

− 3.063

0.002

Lac^a (mmol/L)

2.20 (1.40, 2.40)

2.20 (1.40, 2.40)

− 1.495

0.135

CRP^b (μg/L)

48.00 (27.30, 78.10)

56.80 (35.13, 86.18)

− 2.682

0.007

Crea^b (μmol/L)

66 (53, 80)

59 (51, 76)

− 2.615

0.009

Urea^b (mmol/L)

7.00 (5.40, 10.00)

6.70 (5.25, 9.05)

− 1.087

0.277

CRP^c (μg/L)

75.90 (40.10,105.00)

85.50 (50.65, 111.75)

− 2.518

0.012

Crea^c (μmol/L)

63.50 (51.00,77.80)

57.50 (47.00, 73.00)

− 2.643

0.008

Urea^c (mmol/L)

6.40 (4.80, 9.20)

5.90 (4,30, 8.58)

− 2.013

0.044

WBC^a (10^9/L)

8.03 (6.50, 9.72)

7.94 (6.05, 10.31)

− 0.929

0.353

NEUT%^a (%)

74.39 ± 11.16

61.06 ± 29.24

6.587

0.000

LYM%^a (%)

14.40 (10.80, 18.60)

13.20 (9.55, 18.20)

− 1.713

0.087

PLT^a (10^9/L)

180.89 ± 75.84

184.92 ± 85.58

− 0.590

0.555

WBC^b (10^9/L)

80.79 ± 10.05

10.02 ± 3.32

120.219

0.000

NEUT%^b (%)

99.88 ± 16.29

80.62 ± 13.31

15.438

0.000

Hb^b (g/L)

214.84 ± 88.58

93.95 ± 15.64

24.569

0.000

LYM%^b (%)

9.40 (6.20,12.60)

8.85 (5.83, 12.48)

− 1.083

0.279

PLT^b (10^9/L)

196.10 (151.60, 258.20)

213.00 (164.50, 285.50)

− 2.533

0.011

WBC^c (10^9/L)

7.94 ± 2.41

8.07 ± 2.76

− 0.575

0.566

NEUT%^c (%)

72.96 ± 11.79

74.90 ± 10.67

− 1.990

0.047

Hb^c (g/L)

96.53 ± 15.98

91.08 ± 14.19

4.169

0.000

LYM%^c (%)

14.58 ± 5.76

13.72 ± 6.28

1.678

0.094

PLT^c (10^9/L)

238.27 ± 97.23

244.81 ± 105.67

− 0.760

0.448

PT^a (s)

13.65 ± 1.51

11.96 ± 3.51

6.881

0.000

PTR^a

1.03 (0.99, 1.08)

1.05 (1.01, 1.22)

− 5.110

0.000

INR^a

1.04 (0.99, 1.09)

1.04 (0.99, 1.10)

− 0.666

0.505

PTA^a (%)

95.10 (87.10, 101.20)

89.10 (69.25, 99.10)

− 5.133

0.000

APTT^a (s)

37.72 ± 6.27

49.19 ± 24.07

− 7.054

0.000

TT^a (s)

16.36 ± 4.98

20.44 ± 9.67

− 5.871

0.000

Fbg^a (g/L)

3.95 (3.19, 4.74)

4.28 (3.28, 6.66)

− 3.780

0.000

FDP^a (μg/L)

13.65 (7.90, 32.75)

12.20 (5.15, 25.45)

− 3.132

0.002

D-D^a (mg/L)

5.31 (2.51, 12.37)

7.81 (3.70, 17.86)

− 3.393

0.001

PT^b (s)

13.80 (13.20, 14.30)

13.90 (13.30, 14.60)

− 1.696

0.090

PTR^b

1.05 (1.02, 1.09)

1.06 (1.02, 1.11)

− 1.644

0.100

INR^b

1.09 ± 0.27

1.10 ± 0.13

120.370

0.000

PTA^b (%)

39.53 ± 7.94

87.95 ± 15.83

− 42.716

0.000

APTT^b (s)

16.09 ± 2.66

40.14 ± 9.07

− 38.911

0.000

TT^b(s)

4.63 ± 1.46

15.89 ± 2.98

− 53.004

0.000

Fbg^b (g/L)

4.51 (3.83, 5.22)

4.27 (3.55, 4.91)

− 2.951

0.003

FDP^b (μg/L)

4.60 (4.40, 16.10)

12.30 (6.25, 22.45)

− 3.842

0.000

D-D^b (mg/L)

3.31 (1.42, 6.65)

4.48 (2.15, 7.98)

− 3.730

0.000

PT^c (s)

14.01 ± 6.45

13.62 ± 1.21

0.895

0.371

PTR^c

1.03 (0.99, 1.08)

1.04 (0.99, 1.08)

− 0.685

0.494

INR^c

1.05 ± 0.12

1.06 ± 0.11

− 0.458

0.647

PTA^c (%)

93.41 ± 16.69

93.29 ± 15.24

0.090

0.928

APTT^c (s)

40.00 (36.60, 45.00)

42.10 (37.10, 47.10)

− 2.629

0.009

TT^c (s)

16.07 ± 7.34

16.25 ± 9.34

− 0.254

0.800

Fbg^c (g/L)

5.54 ± 1.57

5.27 ± 1.55

2.093

0.037

FDP^c (μg/L)

9.70 (5.90, 15.00)

10.45 (6.57, 15.53)

− 1.391

0.164

D-D^c (mg/L)

2.98 (1.70, 5.40)

3.37 (2.11, 5.76)

− 1.805

0.071

PT^d (s)

13.30 (12.90, 13.90)

13.40 (12.70, 13.90)

− 0.659

0.510

PTR^d

1.02 (0.99, 1.07)

1.02 (0.98, 1.07)

− 0.261

0.794

INR^d

1.03 (0.99, 1.10)

1.02 (0.97, 1.09)

− 0.886

0.376

PTA^d (%)

90.53 ± 23.31

93.55 ± 20.07

− 0.346

0.135

APTT^d (s)

40.10 (35.03, 44.00)

39.70 (35.90, 43.56)

− 0.106

0.916

TT^d (s)

15.50 (15.00, 16.50)

15.60 (14.80, 16.60)

− 0.405

0.686

Fbg^d (g/L)

5.23 ± 1.90

5.26 ± 1.87

− 0.171

0.864

FDP^d (μg/L)

11.00 (7.19, 16.38)

12.90 (8.50, 22.0)

− 3.879

0.000

D-D^d (mg/L)

4.01 (2.39, 7.06)

5.13 (3.14, 8.37)

− 3.884

0.000